Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston
Novartis at Discovery on Target 2026
Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website
Novartis brings 5 presentations to Discovery on Target 2026 in Boston. Its program centres on radioligand therapies beyond PSMA and on computational design of proximity-inducing drugs. It also covers how ligand and payload design shape the therapeutic index of antibody-drug conjugates, studied with systems pharmacology models.
| Organization | Discovery on Target 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Global pharmaceutical company; Novartis Biomedical Research is its drug discovery arm. | Panel Mon Sep 28 10:45am–11:30am Talk Tue Sep 29 2:20pm–2:50pm Panel Tue Sep 29 5:00pm–6:00pm Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach Novel drug modalitiesInnovative discovery technologies Talk Wed Sep 30 2:05pm–2:35pm Panel Thu Oct 1 7:30am–8:15am |
Instantly find 20 buyers from Novartis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction